These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23018010)

  • 1. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():68-73. PubMed ID: 23018010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():60-6. PubMed ID: 22330158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():66-72. PubMed ID: 24160954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening: present strategies and future prospects.
    Marshall JB
    Postgrad Med; 1996 Mar; 99(3):253-64. PubMed ID: 8637834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon cancer screening and surveillance controversies.
    Lieberman D
    Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for colorectal cancer: recommendations].
    Vonlaufen A; Troillet FX; Armenian B
    Rev Med Suisse; 2013 Apr; 9(381):754-7. PubMed ID: 23659152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer screening in 2010: an up-date.
    Weizman AV; Nguyen GC
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):181-8. PubMed ID: 20485255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.